Kindstar Globalgene Technology, Inc.

HKSE 9960.HK

Kindstar Globalgene Technology, Inc. EBITDA for the year ending December 31, 2023: USD 17.80 M

Kindstar Globalgene Technology, Inc. EBITDA is USD 17.80 M for the year ending December 31, 2023, a -18.50% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Kindstar Globalgene Technology, Inc. EBITDA for the year ending December 31, 2022 was USD 21.84 M, a 109.95% change year over year.
  • Kindstar Globalgene Technology, Inc. EBITDA for the year ending December 31, 2021 was USD -219.51 M, a -57.58% change year over year.
  • Kindstar Globalgene Technology, Inc. EBITDA for the year ending December 31, 2020 was USD -139.29 M, a -692.06% change year over year.
  • Kindstar Globalgene Technology, Inc. EBITDA for the year ending December 31, 2019 was USD -17.59 M, a -592.97% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
HKSE: 9960.HK

Kindstar Globalgene Technology, Inc.

CEO Dr. Shiang Huang
IPO Date July 16, 2021
Location China
Headquarters Biolake D2-1
Employees 3,193
Sector Health Care
Industries
Description

Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.

Similar companies

6622.HK

Zhaoke Ophthalmology Limited

USD 0.18

6.04%

2190.HK

Zylox-Tonbridge Medical Technology Co., Ltd.

USD 1.49

0.32%

9959.HK

Linklogis Inc.

USD 0.18

4.39%

StockViz Staff

January 15, 2025

Any question? Send us an email